“Impact of HIV Subtype on Response and Resistance in Antiretroviral-naïve Adults Comparing Treatment With Once Daily Versus Twice Daily Ritonavir Boosted Fosamprenavir in Combination With Abacavir Lamivudine”. Drugs and Therapy Studies 2, no. 1 (December 30, 2011): e1. Accessed July 1, 2025. https://journals.pagepress.org/dts/article/view/dts.2012.e1.